Table 1 Baselines characteristics
From: Prognostic value of systolic short-term blood pressure variability in systolic heart failure
| N | 288 |
|---|---|
| Age, years | 60 ± 12 |
| Female, n (%) | 61 (21) |
| BMI, Kg/m2 | 26 ± 4 |
| NYHA class, n (%) | |
| I | 16 (6) |
| II | 137 (47) |
| III | 122 (42) |
| IV | 13 (5) |
| Left Ventricular Ejection Fraction, % | 28 ± 9 |
| Hypertension, n (%) | 125 (43) |
| Diabetes, n (%) | 61 (21) |
| Ischemic cardiomyopathy, n (%) | 131 (45) |
| Primitive cardiomyopathy, n (%) | 123 (43) |
| Valvular cardiomyopathy, n (%) | 13 (5) |
| Congestive heart failure, n (%) | 123 (42) |
| ACE inhibitors, n (%) | 239 (83) |
| Beta-Blockers, n (%) | 179 (62) |
| Spironolactone, n (%) | 141 (49) |